Trajan Group Holdings Ltd · ASX:TRJ
Trajan — Investor Day (October 2023)
42 slides from Trajan's investor day presentation, Oct 30, 2023
Slide 1: Trajan Shareholder Day Presentations (ASX Release)
Global Corporate Headquarters 7 Argent Place, Ringwood Victoria 3134, Australia Tel: +61 (0) 3 9837 4200 www.trajanscimed.com Trajan Group Holdings Limited ACN 152 617 706 ASX RELEASE TRAJAN SHAREHOLDER DAY PRESENTATIONS 30 October 2023 – Global analytical science and device company Trajan Group Hol
Slide 2: CEO comment and About Trajan
In commenting on the Shareholder Day, Founder, CEO and Managing Director Mr. Stephen Tomisich said: “We are pleased with the strong response from our existing shareholders and other investors registered to attend today’s inaugural Shareholder in-person event. Our aim is to strengthen the understandi
Slide 3: An Insight into Trajan's Global Clients
INAUGURAL SHAREHOLDER DAY 2023 An Insight into Trajan’s Global Clients SAM EVANS, SENIOR EVP CUSTOMER RELATIONSHIPS – COMPONENTS AND CONSUMABLES
Slide 4: Growing Need for Analytical Solutions
GROWING NEED FOR ANALYTICAL SOLUTIONS TRAJAN WELL POSITIONED TO CAPITALISE • There are hundreds of thousands of laboratories globally, running analytical processes every day. • In each case products such as analytical consumables, sampling devices, pathology consumables, and automated sample prepara
Slide 5: An Industry Partner: Innovative Solutions
AN INDUSTRY PARTNER OEM PARTNERS DISTRIBUTION PARTNERS END USER DIRECT INNOVATIVE SOLUTIONS We provide OEM partners with custom-made Our Distribution Our direct relationships with end users allow us to deliver holistic components, consumables partners offer a workflow solutions, and ‘white glove’ an
Slide 6: An Industry Partner: Diversification at a Glance
AN INDUSTRY PARTNER DIVERSIFICATION AT A GLANCE SCIENCE THAT BENEFITS PEOPLE TRAJAN’S GLOBAL CUSTOMERS
Slide 7: OEMs: Our Path to Have Impact at Scale
OEMs OUR PATH TO HAVE IMPACT AT SCALE • Trajan was founded upon these relationships; they remain the cornerstone of our business. • An 'Impact Multiplier' - Trajan collaborates globally with OEMs to support their brands execution of impact at scale. • A “corporate partner” - we work how our OEMs wor
Slide 8: OEMs: A Typical Partnership Example
OEMs A TYPICAL PARTNERSHIP EXAMPLE • Trajan has had a 10+ relationship. • Relentless customer advocacy by dedicated global account managers. • Originally built on Trajan foundational technologies. • Impact expanded organically across product lines and analytical platforms. Impact Partnership • Each
Slide 9: Global Distributors Supporting End User Sourcing Strategies
GLOBAL DISTRIBUTORS SUPPORTING END USER SOURCING STRATEGIES • A global network of distribution partners. • Supports end users sourcing strategies, partnerships. • Facilitates Trajan branded product impact, exposure. • Key to the broader Trajan value creation lifecycle. SCIENCE THAT BENEFITS PEOPLE T
Slide 10: Direct End User Relationships: Our Innovation Motor
DIRECT END USER RELATIONSHIPS OUR INNOVATION MOTOR • Trajan's direct relationships with end users facilitate critical insight into evolving end user needs. They are the engine of our workflow and consumables innovation. • Market segment focused teams deliver breakthrough holistic solutions across th
Slide 11: Bringing It All Together to Drive Impact
BRINGING IT ALL TOGETHER TO DRIVE IMPACT THE LIFE OF A SOLUTION ! Workflow Launch of Trajan Opportunities Key opinion Trajan solution and/or branded solution to deliver society leaders, early develops Consumables/ promotes, impact at adopters test, a solution Component verifies end user SCALE verify
Slide 12: In Summary: Trajan Well Positioned to Capitalise
IN SUMMARY… TRAJAN WELL POSITIONED TO CAPITALISE If you walk into any of those global analytical process laboratories…....and pick up a consumable or component in our area of core competency…….. regardless of the brand on the box…….or how it was acquired …there is a strong chance that Trajan made it
Slide 13: A New Era in Analytical Workflow at Trajan
INAUGURAL SHAREHOLDER DAY 2023 A New Era in Analytical Workflow at Trajan Carl Beckett, Senior Vice President Workflow Solutions
Slide 14: Analytical Science Integrated by Organising Around Key End Market Segments
ANALYTICAL SCIENCE INTEGRATED BY ORGANISING AROUND KEY END MARKET SEGMENTS • Ensures food safety and quality through • Critical to diagnostics, monitoring treatments, methods that detect and quantify and understanding diseases. contaminants, additives, and nutritional components. • Chromatography, s
Slide 15: Deep Industry and Leadership Experience
DEEP INDUSTRY AND LEADERSHIP EXPERIENCE CROSS FUNCTIONAL AND GEOGRAPHICALLY SPREAD CLINICAL PHARMACEUTICALS FOOD SAFETY ENVIRONMENTAL Cathy Cordova Dr. Kyle Bachus Dr. Andreas Bruchmann Fraser Smith Experience: Experience: Experience: Experience: - Trajan - Trajan - Trajan - Trajan - Neoteryx - Axel
Slide 16: The Journey So Far
THE JOURNEY SO FAR 2016 2021 2021 Acquired Epic Extrusion, Acquired Axel Angela Tomisich 2013 to establish a precision Semrau GmbH. 2022 retires Acquired HD Scientific polymer tubing capability Automation Acquired to add scale to the expansion Chromatography Pathology business unit 2018 Research 202
Slide 17: Acquisition Strategy: Strong End User Touch Points in Core Markets
ACQUISITION STRATEGY STRONG END USER TOUCH POINTS IN CORE MARKETS Deep knowledge in key applications (HDX, MOSH/MOAH, Microsampling) CLINICAL PHARMACEUTICAL CLINICAL PHARMACEUTICAL FOOD / BEVERAGE PHARMACEUTICAL ENVIRONMENTAL Global Americas Germany, Austria, Switzerland SCIENCE THAT BENEFITS PEOPLE
Slide 18: Large and Diverse Portfolio
LARGE AND DIVERSE PORTFOLIO TOUCHING EACH STAGE OF THE ANALYTICAL WORKFLOW Initial sample collection Mitra®, hemaPEN®, Harpera software control of experiments Overall workflow automation, Sample preparation Vials, caps, plates Sample introduction Syringes, fittings Separation products Columns, liner
Slide 19: Understanding Our Customers: Part of the Trajan DNA
UNDERSTANDING OUR CUSTOMERS PART OF THE TRAJAN DNA CLINICAL PHARMACEUTICAL FOOD / BEVERAGE ENVIRONMENTAL GLOBAL, SCALABLE STRATEGIES Understand end user APPLICATIONS/WORKFLOWS Apply the full range of Trajan products and capabilities SCIENCE THAT BENEFITS PEOPLE WORKFLOW SOLUTIONS 7
Slide 20: Increasing Trajan Impact
INCREASING TRAJAN IMPACT APPLYING THE BROADER CAPABILITY TO DELIVER MORE VALUE Deeper and better-informed market Bring the full Trajan expertise to strategies problem solving • Repository/aggregate of knowledge. • Considerable technical capability across • Market trends, technologies, regulations, K
Slide 21: Leverage Shared Resources and Regional Operational Deployment
LEVERAGE SHARED RESOURCES AND REGIONAL OPERATIONAL DEPLOYMENT TO GAIN EFFICIENCY AND INCREASE CUSTOMER INTIMACY CLINICAL PHARMACEUTICAL CLINICAL ENVIRONMENTAL Analytical/Mechanical/Liquid Handling Core elements/supply chain Software roadmap, development, support (incl LIMs, CFR 21) Broad Chronos Dev
Slide 22: Building a Unified Global Brand
WHILE BUILDING A UNIFIED GLOBAL BRAND SOLVING COMPLEX, DIFFICULT ANALYTICAL WORKFLOW PROBLEMS Product Brands Technology Brands SCIENCE THAT BENEFITS PEOPLE WORKFLOW SOLUTIONS 10
Slide 23: Our Opportunities in Motion: Early Traction for Workflow Solutions
OUR OPPORTUNITIES IN MOTION EARLY TRACTION FOR WORKFLOW SOLUTIONS A microsampling customer was needing the lab automation/analytical capability in place to enable adoption of microsampling products • We were able to provide the methods and equipment needed to implement the analytical lab. A major OE
Slide 24: An Insight into Trajan's Global Operations
INAUGURAL SHAREHOLDER DAY 2023 An Insight into Trajan’s Global Operations NIGEL GILLIGAN, CHIEF OPERATING OFFICER
Slide 25: Global Operations Footprint
GLOBAL OPERATIONS FOOTPRINT DRIVING OPERATIONAL CENTRES OF EXCELLENCE (CoE) Melbourne, AU Penang, MY Austin, TX, US Louisville, KY, US Bethel, CT, US Torrance, CA, US Raleigh, NC, US Sprockhövel, DE Headquarters CoE • High Precision • State-of-the-art • Complementary • Separation • High Purity • Mic
Slide 26: Orchestrating Global Supply Network
ORCHESTRATING GLOBAL SUPPLY NETWORK A COMPETITIVE ADVANTAGE Deliver Fundamental Value Proposition Drive E2E Supply Chain Alignment & Optimization High Quality Expand Operations Centres Transform to Drive Growth of Excellence Process Design & Automation Optimal Cost Procurement Strategy & Vendor Enga
Slide 27: Ringwood, Australia: Transitioning Site
RINGWOOD, AUSTRALIA TRANSITIONING SITE Historically sole global design, development and manufacturing location for analytical consumables’ portfolio. Ringwood facility has progressively transformed post 2013 SGE acquisition. Site evolution: • Establishment of Global Operational CoEs, Australia being
Slide 28: Margin Enhancement Actions: Project Neptune
MARGIN ENHANCEMENT ACTIONS PROJECT “NEPTUNE” Some of Trajan’s product lines require labor intensive operations. For those product families we have funded a targeted program called “Project Neptune”. Two work streams; A) Micro Assembly, High Precision Machining & Fabrication in lower cost region Pena
Slide 29: Margin Enhancement Actions: Project Neptune
MARGIN ENHANCEMENT ACTIONS PROJECT “NEPTUNE” B) Flexible Modular Manufacturing Automation. • Automated modular approach key enabler for broad diverse portfolio. • Delivering high reproducibility and consistency, in turn improved analytical outcomes. • Reducing the risk of skills shortages due to an
Slide 30: Science & Engineering
INAUGURAL SHAREHOLDER DAY 2023 Science & Engineering ANDREW GOOLEY, PHD. CHIEF SCIENTIFIC OFFICER
Slide 31: Employee Breakdown by Function
EMPLOYEE BREAKDOWN BY FUNCTION SCIENCE & ENGINEERS Science & Engineers Team Breakdown • Trajan is well supported by a global team of experienced engineers and scientists. • Many have post-graduate qualifications in areas of specialisation such as analytical chemistry, 31 51 mechanical engineering, c
Slide 32: Core Capabilities: Precision Fabrication
CORE CAPABILITIES PRECISION FABRICATION CAPABILITIES Trajan’s global operations infrastructure is equipped 1 2 3 with custom and “State-of-the-Art” fabrication systems: 1. One piece glass-tube flow with modular, interchangeable, value-add and “inspection” modules. 2. High vacuum “plasma enhanced” ch
Slide 33: Core Capabilities: Precision Glass Tubing
CORE CAPABILITIES PRECISION GLASS TUBING • Automated processing and forming accurate diameter borosilicate glass tubing - both outer and inner diameters. • Volumetric precise and accurate analytical syringe barrels – precision wire forming at the submicron scale for mandrels and plungers. • Automati
Slide 34: Core Capabilities: Precision GC & LC Consumables
CORE CAPABILITIES PRECISION GC & LC CONSUMABLES • High purity GC inlet silicone seals – low bleed and high temperature performance. • High vacuum plasma treatment of silicones and polypropylenes – inert surface. • Polymer, Graphite and Steel ferrules – essential sealing components for glass capillar
Slide 35: Core Capabilities: Workflow Automation
CORE CAPABILITIES WORKFLOW AUTOMATION • Synchronised programming of complex sample preparation – CHRONOS software programming. • Automated analysis of edible oils for mineral oil contaminants – MOSH/MOAH. • Automated epitope mapping of next generation therapeutics using Hydrogen-Deuterium. Exchange
Slide 36: Workflow Automation: CHRONOS Enabled
CORE CAPABILITIES WORKFLOW AUTOMATION – CHRONOS ENABLED • Traditional laboratory workflows are too often dependent on batch processing. 7h • Each preparation step of each sample within the batch is processed sequentially. • Ultimately the batch of samples are left idle waiting for the rate limiting
Slide 37: Core Capabilities: Microsampling Solutions
CORE CAPABILITIES MICROSAMPLING SOLUTIONS • Precise and accurate volumetric blood microsampling (10-30 µL) onto a diverse range of substrates – improved efficiency in sample collection from anywhere. • Minimally invasive skin micro biopsies – molecular diagnostics of skin type and sensitive skin con
Slide 38: Collaborations: Clinical Lipidomics
COLLABORATIONS - CLINICAL WORKFLOWS CLINICAL LIPIDOMICS • Collaboration with the Baker Heart & Diabetes Institute. • Unique panel of lipid biomarkers collected using Trajan’s microsampling devices. • CHRONOS sequenced sample preparation followed by fast LC-MS/MS analysis of several hundred lipids. •
Slide 39: Collaborations: Pharmaceutical Workflow Hummingbird
COLLABORATIONS – PHARMACEUTICAL WORKFLOW HUMMINGBIRD • Collaboration with major US pharmaceutical company. • Hummingbird is the development of a compact and modular monitoring system for the FAST workflow – Flexible API Supply Technology (API – active pharmaceutical ingredient). • Hummingbird provid
Slide 40: Hummingbird: Portable LCMS, a PFAS Game Changer
COLLABORATIONS – ENVIRONMENTAL WORKFLOW HUMMINGBIRD – PORTABLE LCMS, A PFAS GAME CHANGER WHAT IS IT USEFUL FOR? • Remote or large sites. • Contamination source tracing. • Validation or treatment optimisation. • Informed delineation. • High throughput activities. • High impact samples. CASE STUDY • R
Slide 41: Hummingbird: Australian Airport Case Study
COLLABORATIONS – ENVIRONMENTAL WORKFLOW HUMMINGBIRD – PORTABLE LCMS, A PFAS GAME CHANGER P-LCMS Commercial Lab AUSTRALIAN AIRPORT CASE STUDY • Samples collected on site and analysed same day using the portable LCMS platform provided acceptable quantitative data as determined by a centralised commerc
Slide 42: Portable LCMS, a PFAS Game Changer
Portable LCMS, A PFAS Game Changer HUMMINGBIRD Comparison (Sample MX019) Certified Reference Material MX019 – 1,000 National Measurement Institute 900 800 700 • Sample run “live” at Ecoforum 2023 PFAS (µg/kg) 600 Oct 11th 2023. • Comparative recoveries of PFAS 500 certified values. 400 300 200 100 0